![]() |
JOURNAL TOOLS |
eTOC |
Per abbonarsi |
Sottometti un articolo |
Segnala alla tua biblioteca |
ARTICLE TOOLS |
Publication history |
Estratti |
Permessi |
Per citare questo articolo |
Share |

I TUOI DATI
I TUOI ORDINI
CESTINO ACQUISTI
N. prodotti: 0
Totale ordine: € 0,00
COME ORDINARE
I TUOI ABBONAMENTI
I TUOI ARTICOLI
I TUOI EBOOK
COUPON
ACCESSIBILITÀ
CASE REPORT
Chirurgia 2019 August;32(4):206-9
DOI: 10.23736/S0394-9508.18.04852-0
Copyright © 2018 EDIZIONI MINERVA MEDICA
lingua: Inglese
Renal cell carcinoma metastasis to neuroendocrine pancreas tumor: case report and literature review
Mariola WINIAREK 1 ✉, Malgorzata MALINOWSKA 2, Piotr SARAMAK 3, Marek SZPAKOWSKI 3, Tomasz OLESIŃSKI 3
1 Department of Oncology, Maria Skodowska-Curie Institute - Oncology Center, Warszawa, Poland; 2 Department of Pathology, Maria Skodowska-Curie Institute - Oncology Center, Warszawa, Poland; 3 Department of Gastroenterological Oncology, Maria Skodowska-Curie Institute - Oncology Center, Warszawa, Poland
The coexistence of two primary neoplasm in one patient is not unusual and two different cancers may even arise at the same anatomic site. However, a metastasis from one tumor to another is significantly rare. A 73-year-old woman, after right-hand nefrectomy 20 years ago because of kidney tumor (no data available) observed for 6 years due to numerous, stable changes in pancreas shown in computer tomography. The latest CT scan confirmed disease progression: numerous PET-CT confirmed neuroendocrine tumors (PNET) clinically without hormonal activity. CT scan suggested metastatic tumor of kidney origin. Complete pancreas resection with splenectomy has been performed. Postoperative histopathological examination revealed NET G1 in pancreas and renal cell carcinoma matastases to neuroendocrine tumor. The diagnosis was confirmed by immunohistochemical staining. Renal cell cancer (RCC) is the most common primary tumor metastasizing to the pancreas, however this is the first report of metastases to neuroendocrine pancreatic tumors. The average time from radical nefrectomy to appearance of metastases to other organs (including pancreas) is 8-10 years. Patients with a history of RCC should undergo a long-term follow-up to detect and evaluate metastasis to pancreas and other organs, but the awareness of the phenomenon of tumor to tumor metastasis is important to avoid an incorrect diagnosis when encountering unusual morphologic features in pancreatic mass.
KEY WORDS: Carcinoma, renal cell - Neuroendocrine tumors - Pancreas